Latest News

GeoVax to Present Zika Vaccine Data at the 20th Annual Conference on Vaccine Research
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company specializing in developing human vaccines, ...
Continue Reading...
GeoVax Awarded $658,000 NIH Grant for its HIV Vaccine Program
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today ...
Continue Reading...
GeoVax Reports on Vaccine Development Progress
Expanding Pipeline for MVA-VLP Vaccine Platform Includes HIV, Zika, Ebola, Malaria, Hepatitis B and...
Continue Reading...